Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProSanos was a healthcare data analytics company that provided longitudinal patient data and research services to the pharmaceutical, biotechnology, and medical device industries. The company specialized in real-world evidence (RWE), utilizing large-scale clinical and claims databases to support drug safety, health economics and outcomes research (HEOR), and market access strategies. Their expertise included post-marketing surveillance and the optimization of clinical trial protocols through data-driven insights. By leveraging proprietary analytical tools, ProSanos helped life science companies understand the long-term safety and efficacy of products in diverse patient populations. In 2010, ProSanos was acquired by Optum, a subsidiary of UnitedHealth Group, to enhance its life sciences data and analytical offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProSanos.